Skip to main content
Premium Trial:

Request an Annual Quote

LJL BioSystems Markets Genotyping Technologies

Premium

SUNNYVALE, Calif.--LJL BioSystems has created a genomics science group within the company to apply its high-throughput screening technologies to the genotyping of single-nucleotide polymorphisms. The company said it has shipped its Analyst system for use in SNP analysis to several genomics customers already, including the Whitehead Institute for Genome Research and Exelixis Pharmaceuticals. The company also recently entered a collaboration with the University of California at Los Angeles in which it will apply what it calls HEFP technology for genotyping to SNPs identified by the university.

Lev Leytes, chairman and CEO of LJL, said, "Initial feedback from our customers who use our high-throughput systems for genomics applications indicates that the requirements of the genomics market are very similar to the emerging requirements of the drug discovery market that LJL is already addressing." He said those customers require both high-throughput and low cost-per-data point, "just like our high-throughput screening customers."

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.